NCT02608060 A Study to Assess the Hematopoyetic Response of Anemic Patients With Hematologic Malignancies Treated With Erythropoietin B Status TERMINATED Phase PHASE4
NCT02605915 Safety and Pharmacokinetics of Atezolizumab Combination Treatments in Participants With HER2-Positive and HER2-Negative Breast Cancer Status COMPLETED Phase PHASE1
NCT02604836 A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia Status COMPLETED Phase PHASE4
NCT02604823 A Study of Peginterferon Alfa-2a (Pegasys) in Participants With Hepatitis B E-Antigen (HBeAg)-Positive Chronic Hepatitis B Virus (HBV) Status COMPLETED Phase PHASE4
NCT02604355 A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO7020322 Following Oral Administration in Healthy Participants and Chronic Hepatitis B Patients Status TERMINATED Phase PHASE1
NCT02604342 Alectinib Versus Pemetrexed or Docetaxel in Anaplastic Lymphoma Kinase (ALK)-Positive Advanced Non-Small Cell Lung Cancer (NSCLC) Participants Previously Treated With Platinum-Based Chemotherapy and Crizotinib Status COMPLETED Phase PHASE3
NCT02600897 A Study of Obinutuzumab, Polatuzumab Vedotin, and Lenalidomide in Relapsed or Refractory Follicular Lymphoma (FL) and Rituximab in Combination With Polatuzumab Vedotin and Lenalidomide in Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Status COMPLETED Phase PHASE1/PHASE2
NCT02600845 ACCU-CHEK Connect Personal Diabetes Management Study (PDM CONNECT) Status COMPLETED Phase NA
NCT02598934 A Study of Ibandronate (Boniva) to Evaluate Bone Turnover Markers in Women With Treatment-Naive Postmenopausal Osteoporosis Status COMPLETED Phase PHASE4
NCT02598453 PRIOR Study - A Study of Ibandronate (Boniva) in Postmenopausal Women With Osteoporosis or Osteopenia Status COMPLETED Phase PHASE4
NCT02598440 A Study of Ibandronate (Bonviva) in Patients With Post-Menopausal Osteoporosis Status COMPLETED Phase PHASE4
NCT02598193 Safety and Tolerability Study of Pirfenidone in Combination With Nintedanib in Participants With Idiopathic Pulmonary Fibrosis (IPF) Status COMPLETED Phase PHASE4
NCT02598167 Participants Preferences to Disease Modifying Agents in Relapsing Remitting Multiple Sclerosis Condition Status COMPLETED Phase N/A
NCT02598063 A Study to Evaluate Efficacy and Safety of Peginterferon Alfa-2a (Pegasys) and Adeforvir Dipivoxil (ADV) in Participants With Lamivudine-Resistant Hepatitis B e Antigen (HBeAg)-Positive Chronic Hepatitis B Status COMPLETED Phase PHASE4
NCT02596971 A Study of Atezolizumab in Combination With Either Obinutuzumab Plus Bendamustine or Obinutuzumab Plus (+) Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) in Participants With Follicular Lymphoma (FL) or Rituximab + CHOP in Participants With Diffuse Large B-Cell Lymphoma (DLBCL) Status COMPLETED Phase PHASE1/PHASE2
NCT02596958 Safety and Efficacy Study of Avastin in Locally Advanced Metastatic or Recurrent Non-small Lung Cancer (NSLC) Participants Status COMPLETED Phase N/A
NCT02596945 Observational Study of Methoxy Polyethylene Glycol Epoetin Beta Daily Use in Participants on Peritoneal Dialysis Status COMPLETED Phase N/A
NCT02595762 A Study of Treatment Patterns and Outcomes in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Unresectable Locally Advanced or Metastatic Breast Cancer Status COMPLETED Phase N/A
NCT02595450 A Non-interventional Trial of Erlotinib (Tarceva) Metastatic Non-small Cell Lung Cancer Status COMPLETED Phase N/A
NCT02593760 A Study to Evaluate the Efficacy and Safety of Vismodegib in Combination With Ruxolitinib for the Treatment of Intermediate- or High-Risk Myelofibrosis (MF) Status COMPLETED Phase PHASE1